Form 4 for ELV Elevance Health
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0001156039-25-000032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-05 | 2025-03-03 | ELV | Penczek Ronald W | CAO, Ctrl | F - Tax | $395.50 | -198 | 1,584 | -11% | -$78.3K |
| DM | 2025-03-05 | 2025-03-03 | ELV | Penczek Ronald W | CAO, Ctrl | A - Grant | $0.00 | +706 | 1,869 | +61% | $0 |
| D | 2025-03-05 | 2025-03-03 | ELV | Penczek Ronald W | CAO, Ctrl | A - Grant | $0.00 | +1,081 | 1,081 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-03 | F | D | 198 | $395.50 | 1,584 | D | — | — | (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. |
| 2 | Common | Common Stock | 2025-03-03 | A | A | 421 | $0.00 | 2,290 | D | — | — | (F3) Represents performance based restricted share units. Restrictions lapse on 3/3/2025. (F4) Balance includes 4.18 shares acquired on March 22, 2024, 3.99 shares acquired on June 25, 2024, 4.07 shares acquired on September 25, 2024 and 5.95 shares acquired on December 20, 2024 through a dividend reinvestment plan. |
| 3 | Common | Common Stock | 2025-03-03 | A | A | 285 | $0.00 | 1,869 | D | — | — | (F2) Represents restricted share units. Restrictions lapse as follows: 95 shares on 3/3/2026, 3/3/2027 and 3/3/2028. |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2025-03-03 | A | A | 1,081 | $0.00 | 1,081 | D | $395.50 · — to 2035-03-03 | 1,081 Common Stock | (F5) The option represents a right to purchase a total of 1,081 shares, and is exercisable in three annual installments, with two installments of 360 shares each and one installment of 361 shares, beginning on 3/3/2026, which is the one-year anniversary of the option grant date. |